Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.
By J. Boxerman, K. Schmainda, R. Weisskoff. AJNR. American journal of neuroradiology, 2006
733 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/4ed9bd7e7bd2ba20ac88855acd7707081fe56862
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Rakesh K. Jain
- D. Duda
- P. Wen
- E. di Tomaso
- T. Batchelor
- Jay S. Loeffler
- A. Sorensen
- Wei-Ting Zhang
Citations in the corpus
- Support vector machines in DSC‐based glioma imaging: Suggestions for optimal characterization (2010, methodology): “To account for both T1- and T2*leakage effects, a pure postprocessing correction routine was applied to the data (25).”
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (2007, background): “, 1996), with blood volume corrected for leakage of the contrast agent across the blood-brain barrier (Boxerman et al., 2006; Law et al., 2002).”
- Classic models for dynamic contrast‐enhanced MRI (2013, unknown): “vp 1⁄4 FpTc; ve 1⁄4 Fp T Tc ð Þ; PS 1⁄4 Fp T Tc Te [36]”